Diffuse large B-cell lymphoma trials in Ireland

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  Where

  Dublin

  Age

  18 years and over

  People

  904 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT06091865 · EU 2022-502785-25-00
• Phase 2Taking people
  A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

  Where

  Dublin 4, Dublin 7, Dublin 8, Dublin 9, Limerick, Waterford

  Age

  18 years and over

  People

  594 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06890884 · EU 2024-515526-89-00
• Phase 2Not yet taking people in Ireland
  HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before

  Where

  Dublin 7, Dublin 8, Dublin 9, Galway, Limerick, Waterford

  Age

  65 years and over

  People

  276 worldwide

  Run by

  Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

  See details and how to join2025-524230-25-00 · EU 2025-524230-25-00